Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
Authors
Stefan Hohaus (ORCID: https://orcid.org/0000-0002-5534-7197)
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
Stefan Hohaus, Ombretta Annibali, Giulio Trapè, Giacinto La Verde et al.
Journal
Frontiers in Oncology
Topics
Viral-associated cancers and disorders
article
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
Stefan Hohaus, Ombretta Annibali, Giulio Trapè, Giacinto La Verde, A. Tafuri, G. Pileggi, A. Di Napoli, G. Palumbo, M. Martelli, L. Filomeno, M. C. Cox, L. Rigacci, A. Di Rocco, E. Maiolo, A. Zizzari, S. Pelliccia, A. Rago, M. P. Bianchi
article en
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in OncologyVol. 16
Institutions
University of Rome Tor Vergata (IT), Università Campus Bio-Medico (IT), ASL Roma (IT), Azienda Ospedaliera Sant'Andrea (IT), Ospedale di Belcolle (IT), University of the Sacred Heart (JP), Sapienza University of Rome (IT)